EXHIBIT 23.1
Published on December 30, 2020
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement Form S-4 of Rexahn Pharmaceuticals, Inc. of our report dated July 1, 2020,
with respect to the financial statements of Ocuphire Pharma, Inc. included in this Current Report on Form 8-K/A.
/s/ Ernst & Young LLP
Detroit, Michigan
December 30, 2020